Standard Article

Tumour Antigens Recognized by T Lymphocytes

  1. Benoît J Van den Eynde1,
  2. Ken C Pang2,
  3. Weisan Chen2

Published Online: 16 APR 2007

DOI: 10.1002/9780470015902.a0001431.pub2

eLS

eLS

How to Cite

Van den Eynde, B. J., Pang, K. C. and Chen, W. 2007. Tumour Antigens Recognized by T Lymphocytes. eLS. .

Author Information

  1. 1

    Ludwig Institute for Cancer Research, and Institute of Cellular Pathology, Université Catholique de Louvain, Brussels, Belgium

  2. 2

    Ludwig Institute for Cancer Research, Melbourne Centre for Clinical Sciences, Austin Health, Heidelberg, Australia

Publication History

  1. Published Online: 16 APR 2007

This is not the most recent version of the article. View current version (15 MAY 2013)

Abstract

Cancer cells bear markers (antigens) that identify them to the immune system, thereby making them targets for destruction by cytolytic T lymphocytes. Therapeutic cancer vaccines designed to exploit our recently gained knowledge of the identity and structure of these antigens are now being tested in clinical trials.

Keywords:

  • tumour antigens;
  • cytotoxic T lymphocytes